Fortis Healthcare Limited (NSE:FORTIS)
India
· Delayed Price · Currency is INR 711.65
-4.65 (-0.65%)
May 30, 2025, 9:30 AM IST
Fortis Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Revenue | 77,828 | 68,929 | 62,976 | 57,176 | 40,301 | Upgrade
|
| Revenue Growth (YoY) | 12.91% | 9.45% | 10.14% | 41.87% | -13.00% | Upgrade
|
| Cost of Revenue | 46,281 | 43,834 | 39,894 | 24,923 | 19,582 | Upgrade
|
| Gross Profit | 31,547 | 25,095 | 23,082 | 32,253 | 20,719 | Upgrade
|
| Selling, General & Admin | - | 3,417 | 3,084 | 2,265 | 1,321 | Upgrade
|
| Other Operating Expenses | 15,668 | 9,100 | 8,997 | 19,340 | 15,308 | Upgrade
|
| Operating Expenses | 19,524 | 15,942 | 15,239 | 24,650 | 19,536 | Upgrade
|
| Operating Income | 12,023 | 9,153 | 7,844 | 7,603 | 1,183 | Upgrade
|
| Interest Expense | -1,844 | -936.01 | -985.87 | -1,194 | -1,408 | Upgrade
|
| Interest & Investment Income | - | 298.94 | 238.29 | 215.48 | 420.13 | Upgrade
|
| Earnings From Equity Investments | 115.2 | 95.1 | 218.4 | 241.47 | 475.59 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | 154.6 | 15.9 | -121 | Upgrade
|
| Other Non Operating Income (Expenses) | 669.4 | -228.3 | -178.43 | -188.94 | -146.17 | Upgrade
|
| EBT Excluding Unusual Items | 10,964 | 8,383 | 7,291 | 6,693 | 403.72 | Upgrade
|
| Impairment of Goodwill | - | - | - | -123.11 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 3.81 | 7.4 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 35.02 | 169.08 | 35.22 | 17.69 | Upgrade
|
| Asset Writedown | -393.8 | - | - | - | - | Upgrade
|
| Legal Settlements | - | -1.9 | -4.35 | -0.53 | -0.57 | Upgrade
|
| Other Unusual Items | -499.6 | 160.2 | 736.1 | 3,273 | 12.12 | Upgrade
|
| Pretax Income | 10,070 | 8,580 | 8,199 | 9,878 | 432.95 | Upgrade
|
| Income Tax Expense | 1,977 | 2,128 | 1,869 | 1,978 | 994.64 | Upgrade
|
| Earnings From Continuing Operations | 8,094 | 6,452 | 6,330 | 7,899 | -561.69 | Upgrade
|
| Net Income to Company | 8,094 | 6,452 | 6,330 | 7,899 | -561.69 | Upgrade
|
| Minority Interest in Earnings | -351.7 | -463.4 | -442.5 | -2,348 | -535.93 | Upgrade
|
| Net Income | 7,742 | 5,989 | 5,887 | 5,551 | -1,098 | Upgrade
|
| Net Income to Common | 7,742 | 5,989 | 5,887 | 5,551 | -1,098 | Upgrade
|
| Net Income Growth | 29.28% | 1.72% | 6.05% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 755 | 755 | 755 | 755 | 755 | Upgrade
|
| Shares Outstanding (Diluted) | 755 | 755 | 755 | 755 | 755 | Upgrade
|
| Shares Change (YoY) | -0.05% | - | - | - | - | Upgrade
|
| EPS (Basic) | 10.26 | 7.93 | 7.80 | 7.35 | -1.45 | Upgrade
|
| EPS (Diluted) | 10.26 | 7.93 | 7.80 | 7.35 | -1.45 | Upgrade
|
| EPS Growth | 29.38% | 1.69% | 6.10% | - | - | Upgrade
|
| Free Cash Flow | 5,770 | 1,576 | 3,750 | 6,499 | 2,670 | Upgrade
|
| Free Cash Flow Per Share | 7.65 | 2.09 | 4.97 | 8.61 | 3.54 | Upgrade
|
| Dividend Per Share | 1.000 | 1.000 | 1.000 | - | - | Upgrade
|
| Gross Margin | 40.53% | 36.41% | 36.65% | 56.41% | 51.41% | Upgrade
|
| Operating Margin | 15.45% | 13.28% | 12.46% | 13.30% | 2.94% | Upgrade
|
| Profit Margin | 9.95% | 8.69% | 9.35% | 9.71% | -2.72% | Upgrade
|
| Free Cash Flow Margin | 7.41% | 2.29% | 5.96% | 11.37% | 6.63% | Upgrade
|
| EBITDA | 15,879 | 11,829 | 10,369 | 9,956 | 3,470 | Upgrade
|
| EBITDA Margin | 20.40% | 17.16% | 16.46% | 17.41% | 8.61% | Upgrade
|
| D&A For EBITDA | 3,856 | 2,676 | 2,525 | 2,353 | 2,288 | Upgrade
|
| EBIT | 12,023 | 9,153 | 7,844 | 7,603 | 1,183 | Upgrade
|
| EBIT Margin | 15.45% | 13.28% | 12.46% | 13.30% | 2.94% | Upgrade
|
| Effective Tax Rate | 19.63% | 24.80% | 22.80% | 20.03% | 229.73% | Upgrade
|
| Revenue as Reported | 78,497 | 69,312 | 63,594 | 57,449 | 40,767 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.